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Abstract
Background: Mediastinitis resulting from surgical site infection may occur in 1% of patients undergoing
median sternotomy. Methods: Case report and review of the pertinent English-language literature.
Results: We report a case of mediastinitis caused by Acinetobacter baumannii, in a patient with multiple
comorbidities who underwent cardiopulmonary bypass. Successful treatment consisted of surgical
debridement, reconstruction, and ampicillin-sulbactam. Conclusions: Acinetobacter baumannii should be
recognized as a potential causative agent of severe postoperative mediastinitis.
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Acinetobacter baumannii Mediastinitis
after Cardiopulmonary Bypass: Case Report
and Literature Review
ELIAS LACHANAS,1 PERIKLIS TOMOS,1 NICOLAOS SFYRAS,2
SPIROS MIYAKIS,3 and ALKIVIADIS KOSTAKIS1

ABSTRACT
Background: Mediastinitis resulting from surgical site infection may occur in 1% of patients
undergoing median sternotomy.
Methods: Case report and review of the pertinent English-language literature.
Results: We report a case of mediastinitis caused by Acinetobacter baumannii, in a patient
with multiple comorbidities who underwent cardiopulmonary bypass. Successful treatment
consisted of surgical debridement, reconstruction, and ampicillin-sulbactam.
Conclusions: Acinetobacter baumannii should be recognized as a potential causative agent
of severe postoperative mediastinitis.

A

CINETOBACTER SPP. are recognized increasingly as pathogens causing nosocomial infections, associated with considerable morbidity [1,2]. We report a patient with multiple risk
factors who developed sternal osteomyelitis
caused by Acinetobacter baumannii after cardiac
surgery. Successful treatment consisted of surgical debridement, followed by reconstruction
using the pectoralis muscles as flaps, combined
with administration of ampicillin-sulbactam.
We discuss the limited number of cases of mediastinitis caused by Acinetobacter spp. reported
in the English-language literature. To the best
of our knowledge, this is the first report of
A. baumannii mediastinitis complicating cardiopulmonary bypass, underlying the idea that
this nosocomial organism should be considered in the differential diagnosis of pathogens
causing severe postoperative infections.

CASE REPORT
A 60-year-old obese (body mass index 34.6),
diabetic, hypertensive female smoker underwent complete myocardial revascularization
using the left internal mammary artery via median sternotomy. An intra-aortic balloon pump
(IABP) inserted via the left femoral artery-supported her low cardiac index for 24 h postoperatively. The postoperative course was complicated by lower-extremity compartment
syndrome, resulting in common peroneal
nerve injury despite fasciotomy. The patient
was discharged on postoperative day 20, otherwise well.
The patient was re-admitted two weeks postdischarge complaining of fever, sternal pain,
and purulent discharge from the sternotomy
scar. The admission temperature was 38.5°C,
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white blood cell count was 3,900/mm3 (89%
neutrophils), C-reactive protein (CRP) concentration was 170 mg/L (normal  5 mg/L), and
erythrocyte sedimentation rate (ESR) was 57
mm/h. The chest radiograph was normal.
Computed tomography (CT) of the chest with
three-dimensional reconstruction revealed extensive necrosis of the sternum (Fig. 1). There
was no evidence of retrosternal space involvement. The patient was treated empirically with
vancomycin for four days (until culture results
were available) without improvement. Blood
cultures were negative. Gram stain of pus from
the sternal wound revealed non-motile gramnegative coccobacilli. The organisms were
strictly aerobic, catalase-positive, and oxidasenegative. On culture (API 20NE system; BioMerieux API, Marcy l’Etoile, France), the isolate was identified as Acinetobacter baumannii,
following the simplified identification scheme
proposed [3]. Susceptibility testing with a broth
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microdilution method performed and interpreted according to standard guidelines [4] revealed the following minimum inhibitory concentrations (MICs) (mcg/mL): ampicillin 16;
ampicillin-sulbactam 1; piperacillin 16; ticarcillin-clavulanic acid 8; cefuroxime 32; cefotaxime 8; ceftazidime 2; cefepime 1; imipenemcilastatin 0.5; gentamicin 1; amikacin 1; and
ciprofloxacin 32.
The diagnosis was postoperative infectious
mediastinitis type IIIB [5] caused by Acinetobacter baumannii, and ampicillin-sulbactam (3 g
every 6 h) was administered intravenously. The
patient underwent pulmonary function tests and
dobutamine stress echocardiography, which revealed small airways disease, no signs of myocardial ischemia, and a left ventricular ejection
fraction of 60%. Therefore, surgical debridement
and sternum reconstruction was undertaken.
During the operation, wires and necrotic
bone, cartilage, and soft tissue were removed,

FIG. 1. Preoperative computed tomography scans of chest with three-dimensional reconstruction. (A) Thoracic cage.
(B) Selected location in sternum, showing necrotic (dark) areas.
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and the sternal defect was reconstructed using
pectoral muscles as flaps [6]. Recovery was uneventful, and the patient was discharged on
oral ampicillin-sulbactam on the tenth postoperative day in excellent physical condition,
with a normal hematologic profile and sternal
stability. Acinetobacter baumannii grew from
culture of the necrotic bone, with an identical
susceptibility pattern.
At follow-up three months later, the patient
was free of symptoms, CRP and ESR were normal, and the surgical site was evaluated with
a repeat three-dimensional CT scan and a threephase 99technetium methylene-diphosphonate
scintigram, revealing normal healing and osteoblastic activity, respectively. Antibiotic
treatment was then discontinued. The patient
remains well; she ceased smoking, and her diabetes control is optimal.

DISCUSSION
Postoperative mediastinitis (surgical site infection associated with sternal osteomyelitis,
with [organ/space] or without [deep incisional] infection of the retrosternal space) occurs in approximately 1% of patients undergoing median sternotomy for cardiopulmonary
bypass [5]. The mortality rate is high (14%–
48%), and the cost of hospitalization is increased [7,8]. Diabetes mellitus, obesity, tobacco smoking, airways disease, the use of the
left internal mammal artery as a graft for cardiopulmonary bypass, and the use of an IABP
are among the risk factors for mediastinitis after sternotomy [9]; all these risk factors were
present in our patient.
Staphylococci (Staphylococcus aureus, S. epidermidis) are isolated in more than 70% of postoperative mediastinitis cases having an identifiable pathogen [10]. Mixed infections, including
anaerobic species, may account for as many as
40% of cases [11]. The extent of the involvement
of anaerobes in mediastinal infections still is debated; growth of these organisms in vitro is often laborious, whereas distinguishing anaerobes
as true pathogens from commensal organisms is
sometimes problematic [12]. Gram-negative organisms and fungi are infrequent isolates in mediastinal surgical site infections [10,11].
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Acinetobacter baumannii is one of at least 21
Acinetobacter species. In clinical practice,
genospecies 1 (A. calcoaceticus), 2 (A. baumannii), 3, and 13 are called Acinetobacter baumannii-calcoaceticus complex, representing approximately 80% of isolates from clinical infections
[13]. In contrast with earlier beliefs (that A. baumannii opportunistically affected patients at
high mortality risk), this organism is now an
established pathogen of hospital infections, associated independently with a higher mortality rate [1,2]. Acinetobacter spp. most often cause
ventilator-associated pneumonia, but may also
cause blood stream infections, as well as other
infections, such as intra-abdominal abscess,
keratitis, and meningitis [1,14]. Acinetobacter
mediastinitis is rare. A case of postoperative
mediastinal infection caused by A. calcoaceticus
has been reported in a patient with esophagotracheal fistula [15], and a case of A. baumannii
(then termed A. anitratus) sternoclavicular septic arthritis has been associated with intravenous drug abuse [16]. To our knowledge, the
case described here is the first reported in the
English-language literature of mediastinal
wound infection caused by A. baumannii after
cardiopulmonary bypass. Interestingly, the
first case of multi-drug-resistant A. baumannii
mediastinitis after heart transplantation has
been described recently [17], identifying this
organism as an emerging pathogen for postoperative infections.
Hospital-acquired infections caused by
Acinetobacter spp. resistant to most broad-spectrum agents (with the usual exception of carbapenems and polymyxins) are encountered
frequently worldwide [14], including our country [18]. The frequency of isolation and the susceptibility pattern of resistant isolates depends
on local factors, such as infection control measures and local antibiotic use policies [14]. Antibiotic combinations have been given for
multi-drug-resistant strains, with inconsistent
outcomes [13]. The strain isolated from the present case was not multi-drug-resistant, and
ampicillin-sulbactam was used. Sulbactam is
active against Acinetobacter (i.e., in comparison
with clavulanate and tazobactam), presumably
because of the selective affinity to its penicillin
binding proteins and more favorable pharmacokinetics [19]. Ampicillin-sulbactam in high
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doses may be considered for the treatment of
multi-drug-resistant strains if imipenem-cilastatin cannot be used or is contraindicated
[13,19].
The optimal surgical treatment of mediastinal infections is debatable, and depends largely
on the extent of tissue damage at the time of
diagnosis [5,10]. When the diagnosis of sternal
infection is delayed more than 20 days, optimal
surgical treatment consists of prompt debridement followed by muscle flaps [10]; the latter
procedure can be performed using the pectoralis muscles [5,6]. In addition to surgery, antibiotics should be administered; in cases with
unidentified pathogens or in mixed infections,
the drugs are directed against a broad spectrum of suspected pathogens, taking into account local patterns of resistance of the most
common pathogens.
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